FP36-WE-02 Clinical outcomes of short-course oral treatment with cladribine tablets for relapsing-remitting multiple sclerosis (RRMS) in the 96-week, phase III, double-blind, placebo-controlled CLARITY study

FP36-WE-02 Clinical outcomes of short-course oral treatment with cladribine tablets for relapsing-remitting multiple sclerosis (RRMS) in the 96-week, phase III, double-blind, placebo-controlled CLARITY study

Saved in:
Bibliographic Details
Published in:Journal of the neurological sciences Vol. 285; p. S114
Main Authors: Giovannoni, G, Comi, G, Cook, S, Rammohan, K, Rieckmann, P, Soelberg-Sørensen, P, Vermersch, P, Chang, P, Hamlett, A, Musch, B, Greenberg, S
Format: Journal Article
Language:English
Published: Elsevier B.V 2009
Subjects:
Neurology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0022-510X
1878-5883
DOI:10.1016/S0022-510X(09)70457-5